Cargando…

A Framework for Prediction of Oncogenomic Progression Aiding Personalized Treatment of Gastric Cancer

Mutations in genes can alter their DNA patterns, and by recognizing these mutations, many carcinomas can be diagnosed in the progression stages. The human body contains many hidden and enigmatic features that humankind has not yet fully understood. A total of 7539 neoplasm cases were reported from 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Alotaibi, Fahad M., Khan, Yaser Daanial
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340236/
https://www.ncbi.nlm.nih.gov/pubmed/37443684
http://dx.doi.org/10.3390/diagnostics13132291
_version_ 1785072030394089472
author Alotaibi, Fahad M.
Khan, Yaser Daanial
author_facet Alotaibi, Fahad M.
Khan, Yaser Daanial
author_sort Alotaibi, Fahad M.
collection PubMed
description Mutations in genes can alter their DNA patterns, and by recognizing these mutations, many carcinomas can be diagnosed in the progression stages. The human body contains many hidden and enigmatic features that humankind has not yet fully understood. A total of 7539 neoplasm cases were reported from 1 January 2021 to 31 December 2021. Of these, 3156 were seen in males (41.9%) and 4383 (58.1%) in female patients. Several machine learning and deep learning frameworks are already implemented to detect mutations, but these techniques lack generalized datasets and need to be optimized for better results. Deep learning-based neural networks provide the computational power to calculate the complex structures of gastric carcinoma-driven gene mutations. This study proposes deep learning approaches such as long and short-term memory, gated recurrent units and bi-LSTM to help in identifying the progression of gastric carcinoma in an optimized manner. This study includes 61 carcinogenic driver genes whose mutations can cause gastric cancer. The mutation information was downloaded from intOGen.org and normal gene sequences were downloaded from asia.ensembl.org, as explained in the data collection section. The proposed deep learning models are validated using the self-consistency test (SCT), 10-fold cross-validation test (FCVT), and independent set test (IST); the IST prediction metrics of accuracy, sensitivity, specificity, MCC and AUC of LSTM, Bi-LSTM, and GRU are 97.18%, 98.35%, 96.01%, 0.94, 0.98; 99.46%, 98.93%, 100%, 0.989, 1.00; 99.46%, 98.93%, 100%, 0.989 and 1.00, respectively.
format Online
Article
Text
id pubmed-10340236
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-103402362023-07-14 A Framework for Prediction of Oncogenomic Progression Aiding Personalized Treatment of Gastric Cancer Alotaibi, Fahad M. Khan, Yaser Daanial Diagnostics (Basel) Article Mutations in genes can alter their DNA patterns, and by recognizing these mutations, many carcinomas can be diagnosed in the progression stages. The human body contains many hidden and enigmatic features that humankind has not yet fully understood. A total of 7539 neoplasm cases were reported from 1 January 2021 to 31 December 2021. Of these, 3156 were seen in males (41.9%) and 4383 (58.1%) in female patients. Several machine learning and deep learning frameworks are already implemented to detect mutations, but these techniques lack generalized datasets and need to be optimized for better results. Deep learning-based neural networks provide the computational power to calculate the complex structures of gastric carcinoma-driven gene mutations. This study proposes deep learning approaches such as long and short-term memory, gated recurrent units and bi-LSTM to help in identifying the progression of gastric carcinoma in an optimized manner. This study includes 61 carcinogenic driver genes whose mutations can cause gastric cancer. The mutation information was downloaded from intOGen.org and normal gene sequences were downloaded from asia.ensembl.org, as explained in the data collection section. The proposed deep learning models are validated using the self-consistency test (SCT), 10-fold cross-validation test (FCVT), and independent set test (IST); the IST prediction metrics of accuracy, sensitivity, specificity, MCC and AUC of LSTM, Bi-LSTM, and GRU are 97.18%, 98.35%, 96.01%, 0.94, 0.98; 99.46%, 98.93%, 100%, 0.989, 1.00; 99.46%, 98.93%, 100%, 0.989 and 1.00, respectively. MDPI 2023-07-06 /pmc/articles/PMC10340236/ /pubmed/37443684 http://dx.doi.org/10.3390/diagnostics13132291 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Alotaibi, Fahad M.
Khan, Yaser Daanial
A Framework for Prediction of Oncogenomic Progression Aiding Personalized Treatment of Gastric Cancer
title A Framework for Prediction of Oncogenomic Progression Aiding Personalized Treatment of Gastric Cancer
title_full A Framework for Prediction of Oncogenomic Progression Aiding Personalized Treatment of Gastric Cancer
title_fullStr A Framework for Prediction of Oncogenomic Progression Aiding Personalized Treatment of Gastric Cancer
title_full_unstemmed A Framework for Prediction of Oncogenomic Progression Aiding Personalized Treatment of Gastric Cancer
title_short A Framework for Prediction of Oncogenomic Progression Aiding Personalized Treatment of Gastric Cancer
title_sort framework for prediction of oncogenomic progression aiding personalized treatment of gastric cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340236/
https://www.ncbi.nlm.nih.gov/pubmed/37443684
http://dx.doi.org/10.3390/diagnostics13132291
work_keys_str_mv AT alotaibifahadm aframeworkforpredictionofoncogenomicprogressionaidingpersonalizedtreatmentofgastriccancer
AT khanyaserdaanial aframeworkforpredictionofoncogenomicprogressionaidingpersonalizedtreatmentofgastriccancer
AT alotaibifahadm frameworkforpredictionofoncogenomicprogressionaidingpersonalizedtreatmentofgastriccancer
AT khanyaserdaanial frameworkforpredictionofoncogenomicprogressionaidingpersonalizedtreatmentofgastriccancer